Yue Qi

1.2k total citations
42 papers, 735 citations indexed

About

Yue Qi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yue Qi has authored 42 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 18 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Yue Qi's work include Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (9 papers) and RNA modifications and cancer (7 papers). Yue Qi is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (9 papers) and RNA modifications and cancer (7 papers). Yue Qi collaborates with scholars based in China, United States and Japan. Yue Qi's co-authors include Bei Lin, Juanjuan Liu, Liancheng Zhu, Yingying Hao, Huaiyu Hu, Anna Żółkiewska, Dawo Liu, Shulan Zhang, Masao Iwamori and Sara Duhachek-Muggy and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Yue Qi

40 papers receiving 728 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yue Qi China	16	561	244	120	100	97	42	735
Emily A. Dennstedt United States	4	509 0.9×	341 1.4×	131 1.1×	66 0.7×	141 1.5×	4	769
Silvia Pegoraro Italy	16	764 1.4×	401 1.6×	84 0.7×	68 0.7×	198 2.0×	37	1.0k
Lucia Cappabianca Italy	19	570 1.0×	282 1.2×	114 0.9×	91 0.9×	185 1.9×	45	944
William Lento United States	12	553 1.0×	126 0.5×	137 1.1×	72 0.7×	156 1.6×	16	880
Coralie Hoareau‐Aveilla France	12	654 1.2×	164 0.7×	52 0.4×	53 0.5×	92 0.9×	17	812
Xiaobo Yang China	16	376 0.7×	248 1.0×	101 0.8×	38 0.4×	101 1.0×	30	622
Pegah Rouhi Sweden	12	590 1.1×	282 1.2×	91 0.8×	289 2.9×	210 2.2×	12	913
Michael E. Feigin United States	16	708 1.3×	119 0.5×	56 0.5×	180 1.8×	214 2.2×	26	914
Dunrui Wang United States	17	419 0.7×	121 0.5×	101 0.8×	143 1.4×	155 1.6×	32	631

Countries citing papers authored by Yue Qi

Since Specialization

Citations

This map shows the geographic impact of Yue Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue Qi more than expected).

Fields of papers citing papers by Yue Qi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yue Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue Qi. The network helps show where Yue Qi may publish in the future.

Co-authorship network of co-authors of Yue Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Yue Qi. A scholar is included among the top collaborators of Yue Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yue Qi. Yue Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Xiao‐Xiao, Weiwei Li, Xinghua Chen, et al.. (2025). USP22 promotes angiotensin II-induced podocyte injury by deubiquitinating and stabilizing HMGB1. Cellular Signalling. 131. 111771–111771. 5 indexed citations

Yang, Hua, Mingyu Li, & Yue Qi. (2023). FOXN3 inhibits the progression of ovarian cancer through negatively regulating the expression of RPS15A. Human Cell. 36(3). 1120–1134. 3 indexed citations

Chen, Yefei, Jingyi Wang, Jing Liu, et al.. (2023). A Novel Retrograde AAV Variant for Functional Manipulation of Cortical Projection Neurons in Mice and Monkeys. Neuroscience Bulletin. 40(1). 90–102. 5 indexed citations

Nie, Xin, Lingling Gao, Mingjun Zheng, et al.. (2021). Overexpression of TMEFF1 in Endometrial Carcinoma and the Mechanism Underlying its Promotion of Malignant Behavior in Cancer Cells. Journal of Cancer. 12(19). 5772–5788. 5 indexed citations

Qi, Yue, Yuanfu Zhang, Yangyang Hao, et al.. (2021). TTSurv: Exploring the Multi-Gene Prognosis in Thousands of Tumors. Frontiers in Oncology. 11. 691310–691310. 4 indexed citations

Wang, Caixia, Shuang Wang, Jing Wang, et al.. (2020). Overexpression of TEM8 promotes ovarian cancer progression via Rac1/Cdc42/JNK and MEK/ERK/STAT3 signaling pathways.. PubMed Central. 12(7). 3557–3576. 13 indexed citations

Guo, Qian, Huimin Wang, Lingling Gao, et al.. (2020). miR-5193, regulated by FUT1, suppresses proliferation and migration of ovarian cancer cells by targeting TRIM11. Pathology - Research and Practice. 216(11). 153148–153148. 14 indexed citations

Yang, Hua, et al.. (2020). Down-regulation of lncRNA BLACAT1 inhibits ovarian cancer progression by suppressing the Wnt/β-catenin signaling pathway via regulating miR-519d-3p. Molecular and Cellular Biochemistry. 467(1-2). 95–105. 19 indexed citations

Wang, Caixia, Mingjun Zheng, Shuang Wang, et al.. (2019). Whole Genome Analysis and Prognostic Model Construction Based on Alternative Splicing Events in Endometrial Cancer. BioMed Research International. 2019. 1–10. 16 indexed citations

10.

Zhang, Wenchao, Lingling Gao, Caixia Wang, et al.. (2019). Combining Bioinformatics and Experiments to Identify and Verify Key Genes with Prognostic Values in Endometrial Carcinoma. Journal of Cancer. 11(3). 716–732. 33 indexed citations

11.

Liu, Yaxin, Xiaowen Wang, Yuan Yang, et al.. (2019). Mitochondrial carrier protein overloading and misfolding induce aggresomes and proteostatic adaptations in the cytosol. Molecular Biology of the Cell. 30(11). 1272–1284. 30 indexed citations

12.

Duhachek-Muggy, Sara, et al.. (2016). Protein disulfide isomerases in the endoplasmic reticulum promote anchorage-independent growth of breast cancer cells. Breast Cancer Research and Treatment. 157(2). 241–252. 31 indexed citations

13.

Lin, Chen, et al.. (2015). Acute toxic effects of sonodynamic therapy on hypertrophic scar fibroblasts of rabbit ears. Genetics and Molecular Research. 14(2). 4203–4214. 5 indexed citations

14.

Qi, Yue, Sara Duhachek-Muggy, Hui Li, & Anna Żółkiewska. (2014). Phenotypic Diversity of Breast Cancer-Related Mutations in Metalloproteinase-Disintegrin ADAM12. PLoS ONE. 9(3). e92536–e92536. 12 indexed citations

15.

Li, Hui, et al.. (2012). An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancer. Breast Cancer Research and Treatment. 135(3). 759–769. 30 indexed citations

16.

Qi, Yue, Jianjun Liu, Chuang Ma, et al.. (2011). Influence of 144 candidate genetic polymorphisms on statin treatment in Han Chinese. Heart. 97(Suppl 3). A69–A70. 1 indexed citations

17.

Liu, Juanjuan, Bei Lin, Yue Qi, et al.. (2010). Inhibitory effect of α-L-fucosidase on Lewis y antigen overexpressed human ovarian cancer cells in vitro.. 39(5). 321–324. 1 indexed citations

18.

Liu, Juanjuan, Bei Lin, Yingying Hao, et al.. (2010). Lewis(y) antigen stimulates the growth of ovarian cancer cells via regulation of the epidermal growth factor receptor pathway.. PubMed. 23(3). 833–41. 58 indexed citations

19.

Hu, Huaiyu, et al.. (2010). Conditional knockout of protein O‐mannosyltransferase 2 reveals tissue‐specific roles of O‐mannosyl glycosylation in brain development. The Journal of Comparative Neurology. 519(7). 1320–1337. 41 indexed citations

20.

Chang, Min, et al.. (2002). [Nphe¹]nociceptin(113)-NH₂ antagonizes nociceptin-induced hypotension, bradycardia, and hindquarters vasodilation in the anesthetized rat. Canadian Journal of Physiology and Pharmacology. 80(1). 31–35. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact